tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Dr. Reddy’s Russian Subsidiary Faces VAT Reclassification Penalty Deemed Immaterial
PremiumCompany AnnouncementsDr. Reddy’s Russian Subsidiary Faces VAT Reclassification Penalty Deemed Immaterial
19d ago
Is RDY a Buy, Before Earnings?
Premium
Pre-Earnings
Is RDY a Buy, Before Earnings?
26d ago
Dr. Reddy’s Launches First-to-Market Generic of Extra-Strength Pataday in U.S. OTC Eye-Care Segment
Premium
Company Announcements
Dr. Reddy’s Launches First-to-Market Generic of Extra-Strength Pataday in U.S. OTC Eye-Care Segment
30d ago
Dr. Reddy’s Schedules January 21 Board Meeting to Review Q3 FY26 Results, Closes Trading Window
PremiumCompany AnnouncementsDr. Reddy’s Schedules January 21 Board Meeting to Review Q3 FY26 Results, Closes Trading Window
2M ago
Dr. Reddy’s Laboratories to Engage with Investors at Chennai Conference
Premium
Company Announcements
Dr. Reddy’s Laboratories to Engage with Investors at Chennai Conference
2M ago
Dr. Reddy’s Laboratories Receives USFDA Observations Post-Inspection
Premium
Company Announcements
Dr. Reddy’s Laboratories Receives USFDA Observations Post-Inspection
2M ago
Dr. Reddy’s Laboratories to Engage with Investors at Singapore Conference
PremiumCompany AnnouncementsDr. Reddy’s Laboratories to Engage with Investors at Singapore Conference
2M ago
Dr. Reddy’s Laboratories to Engage with Investors at Tokyo Conference
Premium
Company Announcements
Dr. Reddy’s Laboratories to Engage with Investors at Tokyo Conference
3M ago
Dr. Reddy’s Gains EU Approval for Denosumab Biosimilar
Premium
Company Announcements
Dr. Reddy’s Gains EU Approval for Denosumab Biosimilar
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100